about us
Inspira Technologies is an innovative medical technology company in the respiratory treatment arena. Inspira was incorporated in 2018 with a clear mission: to develop a cost-effective, less-invasive respiratory support system as an alternative to mechanical ventilation used today to save the lives of patients with acute respiratory failure.
The company’s first-of-its-kind early extracorporeal respiratory support system, The ART device, is designed to elevate and stabilize patient oxygen saturation levels while the patient is awake.
The ART device is intended as an artificial assisting lung. It withdraws blood through a dual lumen cannula inserted into the jugular vein, enriches it with a high concentration of oxygen, removes CO2, and returns the enriched blood to rebalance patients’ saturation levels and take the load off the lungs.
Redefining Artificial Respiration to impact millions of lives
We are a specialty medical device company developing proprietary respiratory support technology designed to prevent the need for mechanical ventilation which is the current standard of care.
management
meet our team
Joe Hayon
Co-Founder, President, and CFO
Joe has executed M&As and strategic joint ventures, and holds deep experience in manufacturing and setting up operations to support high-growth delivery.
Dagi Ben-Noon
Co-Founder and CEO
Dagi is a serial entrepreneur and investor with multi-industry experience in growing companies from concept to market penetration and sales.
Prof. Benad Goldwasser
Chairman
Benad is a Urologic Surgeon, inventor, entrepreneur, and venture capital investor with vast experience in leading high-growth, publicly-traded medical companies.
Udi Nussinovitch, MD-PhD
Co-Founder and Chief Scientific Officer
Udi is a board-certified Cardiologist, ICU Physician, and Cardiology Researcher, as well as a senior hyperbaric and diving physician.
